AVANDIA
GSK Defends Its Record on Avandia Washington -- Responding to a study published in the New England Journal of Medicine that highlights cardiovascular problems linked to GlaxoSmithKline's (GSK) diabetes drug Avandia, Senators Max Baucus (D-MT), Chairman of the Committee on Finance, and Chuck Grassley (R-IA), ranking member of the committee, sent letters to FDA Commissioner Andrew C.